Literature DB >> 35344864

Delve into Multiple Sclerosis (MS) lesion exploration: A modified attention U-Net for MS lesion segmentation in Brain MRI.

Maryam Hashemi1, Mahsa Akhbari2, Christian Jutten3.   

Abstract

Multiple Sclerosis (MS) is a Central Nervous System (CNS) disease that Magnetic Resonance Imaging (MRI) system can detect and segment its lesions. Artificial Neural Networks (ANNs) recently reached a noticeable performance in finding MS lesions from MRI. U-Net and Attention U-Net are two of the most successful ANNs in the field of MS lesion segmentation. In this work, we proposed a framework to segment MS lesions in Fluid-Attenuated Inversion Recovery (FLAIR) and T2 MRI images by modified U-Net and modified Attention U-Net. For this purpose, we developed some extra preprocessing on MRI scans, made modifications in the loss function of U-Net and Attention U-Net, and proposed using the union of FLAIR and T2 predictions to reach a better performance. Results show that the union of FLAIR and T2 predicted masks by the modified Attention U-Net reaches the performance of 82.30% in terms of Dice Similarity Coefficient (DSC) in the test dataset, which is a considerable improvement compared to the previous works.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Attention U-Net; Brain MRI; Lesion detection; Multiple Sclerosis (MS); Segmentation; U-Net

Mesh:

Year:  2022        PMID: 35344864     DOI: 10.1016/j.compbiomed.2022.105402

Source DB:  PubMed          Journal:  Comput Biol Med        ISSN: 0010-4825            Impact factor:   4.589


  2 in total

1.  SegChaNet: A Novel Model for Lung Cancer Segmentation in CT Scans.

Authors:  Mehmet Akif Cifci
Journal:  Appl Bionics Biomech       Date:  2022-05-14       Impact factor: 1.664

2.  New MS lesion segmentation with deep residual attention gate U-Net utilizing 2D slices of 3D MR images.

Authors:  Beytullah Sarica; Dursun Zafer Seker
Journal:  Front Neurosci       Date:  2022-07-22       Impact factor: 5.152

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.